BMY Stock: Price, Earnings History and SEC Filings
Bristol-Myers Squibb Company (BMY) last traded at $62.48, up 1.78% on the latest session and up 0.1% over the past month. In its most recent reported quarter (Sep 2026) earnings per share were $1.35 against an analyst estimate of $1.21, a beat of 11.6%.
$62.48 +1.78%
1 month+0.13%
52-week high$68.64
52-week low$45.27
Volume12.67M
ExchangeNYSE
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
BMY earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Sep 2026 | Oct 29, 2026 | $1.35 | $1.21 | +11.57% |
| Jun 2026 | Jul 30, 2026 | $2.04 | $1.59 | +28.30% |
| Mar 2026 | Apr 30, 2026 | $1.58 | $1.44 | +9.72% |
| Dec 2025 | Feb 5, 2026 | $1.26 | $1.15 | +9.57% |
BMY beat the analyst EPS estimate in 4 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for BMY
SEC filing data is not available right now. You can search for BMY on SEC EDGAR.
BMY news
- What Bristol Myers Squibb Stock's Earnings Beat Means For ShareholdersOct 31, 2026 · finance.yahoo.com
- Bristol Myers Squibb (BMY) Reports Positive Phase 2 Pumitamig Lung Cancer DataOct 31, 2026 · finance.yahoo.com
- MarketBeat Week in Review – 10/26 - 10/30Oct 31, 2026 · marketbeat.com
- AstraZeneca Has an $80 Billion Dream and a Plan to Fix Its Stalling StockOct 30, 2026 · finance.yahoo.com
- BMY Q3 Earnings Call Highlights Raised Outlook and Pipeline ProgressOct 30, 2026 · finance.yahoo.com
- Pfizer Yields Nearly 6%, but Its Dividend Exceeds Free Cash Flow. Is It Safe?Oct 30, 2026 · 247wallst.com
- Is 50% Crash Risk For Iovance Stock Real?Oct 30, 2026 · trefis.com
- Eli Lilly’s tirzepatide outperforms big pharma companies in Q3Oct 30, 2026 · pharmaceutical-technology.com
About Bristol-Myers Squibb Company
Bristol-Myers Squibb Company (BMY) is a US-listed public company on NYSE.